Intraocular sarcoidosis: Association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography

British Journal of Ophthalmology

Volumn 96, Issue 1, 2012, Pages 99-103

  Rahmi, Ahmed ^a,d   Deshayes, Emmanuel ^b   Maucort Boulch, Delphine ^c,d   Varron, Loig ^a,d   Grange, Jean Daniel ^a,d   Kodjikian, Laurent ^a,d   Seve, Pascal ^a,d  

^a CROIX ROUSSE HOSPITAL   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE BIOPSY; EYE SYNECHIA; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; HYPERMETABOLISM; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; UVEITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FEMALE; FLUORODEOXYGLUCOSE F18; GRANULOMA; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED; UVEITIS; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84455193928     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.194514     Document Type: Article

References (26)

1. Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care Med 2010;31:452-62.
2. Stavrou A, Foster S. Sarcoidosis. In: Foster S, Vitale A, eds. Diagnosis and Treatment of Uveitis. Philadelphia: W.B. Saunders Company, 2002:710-25.
3. Abad S, Meyssonier V, Allali J, et al. Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Rheum 2004;51:974-82. (Pubitemid 39648191)
4. Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009;17:160-9.
5. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45:1989-98. (Pubitemid 47611626)
6. Ota K, Tsunemi T, Saito K, et al. 18F-FDG PET successfully detects spinal cord sarcoidosis. J Neurol 2009;256:1943-6.
7. Dubey N, Miletich RS, Wasay M, et al. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci 2002;205:77-81. (Pubitemid 36158997)
8. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538-43. (Pubitemid 41373496)
9. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006;47:1571-6. (Pubitemid 47545019)
10. Costabel U, Bonella F, Ohshimo S, et al. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med 2010;31:404-8.
11. Prager E, Wehrschuetz M, Bisail B, et al. Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging. Nuklearmedizin 2008;47:18-23. (Pubitemid 351272806)
12. Teirstein AS, Machac J, Almeida O, et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007;132:1949-53.
13. Keijsers RG, Grutters JC, Thomeer M, et al. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of 67Ga imaging and 18F-FDG PET. Q J Nucl Med Mol Imaging Q J Nucl Med Mol Imaging. 2011;55:66-71.
14. Gotthardt M, Bleeker-Rovers CP, Boerman OC, et al. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med 2010;51:1937-49.
15. Morgenthau AS, Iannuzzi MC. Recent advances in sarcoidosis. Chest 2011;139:174-82.
16. Braun JJ, Kessler R, Constantinesco A, et al. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008;35:1537-43.
17. Seve P, Billotey C, Janier M, et al. Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis. Ocul Immunol Inflamm 2009;17:179-84.
18. Tannen BL, Ghesani NV, Frohman L, et al. Use of whole-body FDG PET-CT to aid in the diagnosis of occult sarcoidosis. Ocul Immunol Inflamm 2008;16:25-7. (Pubitemid 351480325)
19. Shulman JP, Latkany P, Chin KJ, et al. Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: ophthalmic oncology and uveitis. Ocul Immunol Inflamm 2009;17:95-100.
20. Wakefield D, Zierhut M. Controversy: ocular sarcoidosis. Ocul Immunol Inflamm 2010;18:5-9.
21. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140:509-16. (Pubitemid 41224845)
22. Kaiser PK, Lowder CY, Sullivan P, et al. Chest computerized tomography in the evaluation of uveitis in ederly women. Am J Ophthalmol 2002;133:499-505. (Pubitemid 34258058)
23. Clement D, Postma G, Rothova A, et al. Intraocular sarcoidosis: association of clinical characteristics of uveitis with positive chest high-resolution computed tomography findings. Br J Ophthalmol 2010;94:219-22.
24. Kantrow SP, Meyer KC, Kidd P, et al. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997;10:2716-21. (Pubitemid 28052776)
25. Yanardag H, Pamuk ON. Older sarcoidosis patients: experience of a medical center in Turkey. South Med J 2004;97:472-4. (Pubitemid 38623778)
26. Hassenstein A, Bialasiewicz AA, Knospe V, et al. Incidence of ocular manifestations in patients with histologically confirmed systemic sarcoidosis. Klin Monbl Augenheilkd 2003;220:414-17. (Pubitemid 36874952)